MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2025 International Congress

    Severe Dopaminergic Deficits in Early Stage Genetically-Confirmed Perry Syndrome

    E. Roddy, V. Holiday, P. Hedera (Louisville, USA)

    Objective: To describe the evidence for severe dopaminergic deficit in early stages of genetically confirmed Perry syndrome Background: PS is a neurodegenerative disease comprised of…
  • 2025 International Congress

    Parkinsonism in KMT5B-related Disorders: Expanding the Spectrum.

    P. Rábano-Suárez, A. Sánchez-Ferro, A. Arteche-López, JF. Quesada, R. Pérez, M. Morales, L. Jiménez Díez-Canseco, A. Galiana, A. Méndez-Guerrero (Madrid, Spain)

    Objective: To describe a novel association between parkinsonism and a pathogenic variant in the KMT5B gene, expanding the clinical spectrum of KMT5B-related disorders. Background: Neuropsychiatric…
  • 2025 International Congress

    The importance of vascular anomalies and endothelin-1 factor in the development of vascular parkinsonism

    R. Juraev, R. Matmurodov, S. Jumanazarova (Tashkent, Uzbekistan)

    Objective: To study the relationship between vascular endothelium and vascular anomalies in the development of vascular parkinsonism. Background: Although vascular parkinsonism (VP) is relatively rare,…
  • 2025 International Congress

    The Sedentary Index (SI) for Daily Life Activity Monitoring in Progressive Supranuclear Palsy (PSP)

    M. Dale, C. Silva-Batista, A. Ragothaman, Z. Nhem, A. Lawston, G. Harker, D. Maxwell, C. Speirs, D. Loudon, M. Mancini (Portland, USA)

    Objective: To confirm the feasibility of daily life physical activity monitoring in PSP using a single activPAL sensor, and to examine preliminary associations between overall…
  • 2025 International Congress

    The IMPACT study: protocol of a randomised controlled single-blind trial evaluating efficacy and cost-effectiveness of telenursing in atypical parkinsonism

    R. Cilia, V. Leta, F. Colucci, A. Suppa, F. Valentino, C. Terranova, C. Leuzzi, J. Cordasco, G. Fusi, S. Floridia, F. de Giorgi, R. Telese, A. Braccia, A. Zampogna, G. Pinola, M. Patera, G. Belluscio, S. Crivellari, E. Antoniazzi, S. Cascino, A. Giaco, A. Masaracchio, G. Moreschi, M. Catotti, R. Eleopra (Milan, Italy)

    Objective: To present the protocol of a study evaluating the efficacy and cost-effectiveness of a 12-month integrated program aimed at improving healthcare delivery and coordinated…
  • 2025 International Congress

    Survey of knowledge and training needs of professionals in nursing homes for Parkinson’s disease

    J. Thezenas, M. Heuzé-de Raeve (Eaubonne, France)

    Objective: Understand the initial knowledge of Nursing home professionals. Target the learning weaknesses. Generate spontaneous demand for training spontaneous demand for training and topics to help professionals…
  • 2025 International Congress

    Chronic kidney disease, proteinuria, and mortality risk in patients with Parkinson’s disease: A longitudinal study

    K. Baik, M. Park, M. Kang, YJ. Park, SJ. Chung, K. Oh, SH. Kang, S. Koh (Seoul, Republic of Korea)

    Objective: To investigate whether chronic kidney disease (CKD) and proteinuria are associated with mortality rates in patients with Parkinson's disease (PD), using data from a large…
  • 2025 International Congress

    A Prospective, Observational Study to Identify Biomarkers in Parkinsonian Syndromes (proATYP).

    M. Makrygianni, D. Potamianou, T. Pipikos, M. Xilouri, C. Mourmouris, A. Sarafi, L. Florentin, M. Stamelou (Athens, Greece)

    Objective: This is a prospective observational study to identify biomarkers in parkinsonian syndromes. Background: Parkinson’s disease (PD) and atypical parkinsonian syndromes namely progressive supranuclear palsy…
  • 2025 International Congress

    Secular trends and survival of Parkinson’s disease and other forms of parkinsonism in the United Kingdom

    S. Gandhi, K. Grosset, P. Iruthayaraj, R. Gravesande, L. Lee, C. Doyle, Y. Ben-Shlomo, D. Grosset (Glasgow, United Kingdom)

    Objective: We examined the UK incidence, prevalence and survival for eight parkinsonian disorders including Parkinson’s disease (PD) from 2003 to 2023, using primary and secondary…
  • 2025 International Congress

    Early-onset levodopa-responsive parkinsonism with cognitive impairment and head-bobbing dyskinesias associated with SYNJ1 and GBA variants of unknown significance

    S. Rodrigo, M. Rosenbaum, J. Fleisher (Chicago, USA)

    Objective: Describe the clinical and diagnostic findings of a patient with early-onset Parkinson’s Disease (EOPD) with homozygous variant of unknown significance (VUS) in the SYNJ1…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley